Clinical trial
Effect of OPRM1 Genotype on the Dose Response to Spinal Morphine for Post-Cesarean Analgesia
NCT01465191 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of OPRM1 Genotype on the Dose Response to Spinal Morphine for Post-Cesarean Analgesia
- Lead sponsor
- Columbia University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- May 31, 2014
- Enrollment
- 169 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.